ā Back to Trial
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Trial Locations
-
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, United States
- Contact: Susan Sharry Ā· 801-585-3453 Ā· [email protected] (opens in new tab)

